A decreased expression of E-cadherin has been shown to affect HCC progression58, linked to periportal fibrosis59 and has been associated with decreased mitochondrial membrane potential in tumor microenvironments60. The gene discussed is CDH1; the disease is hepatocellular carcinoma.